Skip to main content

Table 3 Preferred terms associated with adverse hyperglycemia in the Standardized MedDRA Queries (SMQ; 20000041)

From: Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports

Preferred terms

Code

Total

Atypical

Typical

   

Cases *

Reporting ratio (%)

Cases *

Reporting ratio (%)

Total

 

241478

21151

8.8

3948

1.6

Abnormal loss of weight

10000159

532

28

5.3

9

1.7

Abnormal weight gain

10000188

134

33

24.6

0

0

Acidosis

10000486

1956

102

5.2

44

2.2

Altered state of consciousness

10001854

3306

303

9.2

111

3.4

Anti-GAD antibody positive

10059728

23

2

8.7

0

0

Anti-insulin antibody increased

10053815

51

0

0

0

0

Anti-insulin antibody positive

10053814

115

0

0

0

0

Anti-insulin receptor antibody increased

10068226

0

0

0

0

0

Anti-insulin receptor antibody positive

10068225

3

0

0

0

0

Anti-islet cell antibody positive

10049439

4

1

25

0

0

Blood 1,5-anhydroglucitol decreased

10065367

0

0

0

0

0

Blood cholesterol increased

10005425

10887

1648

15.1

63

0.6

Blood glucose abnormal

10005554

1547

116

7.5

12

0.8

Blood glucose fluctuation

10049803

2267

76

3.4

6

0.3

Blood glucose increased

10005557

35838

1398

3.9

241

0.7

Blood insulin abnormal

10005606

7

0

0

0

0

Blood insulin decreased

10005613

23

1

4.3

1

4.3

Blood lactic acid increased

10005635

826

47

5.7

6

0.7

Blood osmolarity increased

10005697

112

16

14.3

3

2.7

Blood triglycerides increased

10005839

5404

1199

22.2

35

0.6

Body mass index decreased

10005895

59

14

23.7

0

0

Body mass index increased

10005897

112

29

25.9

0

0

Central obesity

10065941

81

7

8.6

1

1.2

Coma

10010071

10703

1018

9.5

253

2.4

Dehydration

10012174

27804

1067

3.8

1025

3.7

Depressed level of consciousness

10012373

10200

819

8

333

3.3

Diabetes complicating pregnancy

10012596

3

1

33.3

0

0

Diabetes mellitus

10012601

15780

5523

35

98

0.6

Diabetes mellitus inadequate control

10012607

3689

825

22.4

25

0.7

Diabetes with hyperosmolarity

10012631

27

8

29.6

0

0

Diabetic coma

10012650

1045

551

52.7

1

0.1

Diabetic hepatopathy

10071265

0

0

0

0

0

Diabetic hyperglycaemic coma

10012668

80

7

8.8

1

1.3

Diabetic hyperosmolar coma

10012669

170

66

38.8

7

4.1

Diabetic ketoacidosis

10012671

2725

1090

40

26

1

Diabetic ketoacidotic hyperglycaemic coma

10012672

32

6

18.8

0

0

Fructosamine increased

10017395

5

0

0

0

0

Gestational diabetes

10018209

594

140

23.6

15

2.5

Glucose tolerance decreased

10018428

13

0

0

0

0

Glucose tolerance impaired

10018429

1058

260

24.6

6

0.6

Glucose tolerance impaired in pregnancy

10018430

3

1

33.3

0

0

Glucose tolerance test abnormal

10018433

36

3

8.3

0

0

Glucose urine present

10018478

318

23

7.2

15

4.7

Glycosuria

10018473

384

140

36.5

5

1.3

Glycosuria during pregnancy

10018475

1

0

0

0

0

Glycosylated haemoglobin increased

10018484

2569

171

6.7

11

0.4

Hunger

10020466

1575

142

9

8

0.5

Hypercholesterolaemia

10020603

2210

256

11.6

26

1.2

Hyperglycaemia

10020635

7844

1382

17.6

129

1.6

Hyperglycaemic hyperosmolar nonketotic syndrome

10063554

184

98

53.3

7

3.8

Hyperglycaemic seizure

10071394

5

0

0

0

0

Hyperglycaemic unconsciousness

10071286

10

0

0

0

0

Hyperlactacidaemia

10020660

333

13

3.9

5

1.5

Hyperlipidaemia

10062060

4585

747

16.3

45

1

Hyperosmolar state

10020697

113

24

21.2

3

2.7

Hyperphagia

10020710

632

157

24.8

4

0.6

Hypertriglyceridaemia

10020869

1127

154

13.7

14

1.2

Hypoglycaemia

10020993

10839

672

6.2

99

0.9

Hypoinsulinaemia

10070070

1

0

0

0

0

Impaired fasting glucose

10056997

67

22

32.8

0

0

Impaired insulin secretion

10052341

21

0

0

0

0

Increased appetite

10021654

2646

494

18.7

21

0.8

Increased insulin requirement

10021664

31

2

6.5

0

0

Insulin autoimmune syndrome

10022472

23

0

0

0

0

Insulin resistance

10022489

297

75

25.3

0

0

Insulin resistance syndrome

10022490

18

6

33.3

0

0

Insulin resistant diabetes

10022491

27

8

29.6

0

0

Insulin tolerance test abnormal

10022494

3

0

0

0

0

Insulin-requiring type 2 diabetes mellitus

10053247

122

60

49.2

0

0

Ketoacidosis

10023379

640

250

39.1

3

0.5

Ketonuria

10023388

188

63

33.5

5

2.7

Ketosis

10023391

100

13

13

3

3

Lactic acidosis

10023676

4561

119

2.6

61

1.3

Latent autoimmune diabetes in adults

10066389

16

0

0

0

0

Lipids increased

10024592

368

57

15.5

1

0.3

Loss of consciousness

10024855

28249

1750

6.2

355

1.3

Metabolic acidosis

10027417

5512

253

4.6

121

2.2

Metabolic syndrome

10052066

392

197

50.3

2

0.5

Neonatal diabetes mellitus

10028933

3

0

0

1

33.3

Obesity

10029883

2787

1211

43.5

23

0.8

Overweight

10033307

442

114

25.8

3

0.7

Pancreatogenous diabetes

10033660

6

2

33.3

0

0

Polydipsia

10036067

1026

271

26.4

16

1.6

Polyuria

10036142

1444

197

13.6

27

1.9

Slow response to stimuli

10041045

161

37

23

7

4.3

Thirst

10043458

2595

224

8.6

40

1.5

Type 1 diabetes mellitus

10067584

1252

590

47.1

7

0.6

Type 2 diabetes mellitus

10067585

5272

2862

54.3

16

0.3

Underweight

10048828

111

8

7.2

2

1.8

Unresponsive to stimuli

10045555

5657

442

7.8

123

2.2

Urine ketone body present

10057597

304

31

10.2

13

4.3

Weight decreased

10047895

42275

1765

4.2

466

1.1

Weight increased

10047899

30417

5070

16.7

867

2.9

  1. *With adverse events of interest.